Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.
Yun MR, Choi HM, Lee YW, Joo HS, Park CW, Choi JW, Kim DH, Kang HN, Pyo KH, Shin EJ, Shim HS, Soo RA, Yang JC, Lee SS, Chang H, Kim MH, Hong MH, Kim HR, Cho BC.
Yun MR, et al. Among authors: shim hs.
EMBO Mol Med. 2019 Dec;11(12):e10581. doi: 10.15252/emmm.201910581. Epub 2019 Oct 21.
EMBO Mol Med. 2019.
PMID: 31633304
Free PMC article.